SCHEMBL7011998

SCHEMBL7011998

Cc1cc(-n2ccnc2)c2cccc(OCc3c(Cl)ccc(-n4cccc4C(N)C(=O)/C=C/c4ccc(C(=O)Nc5ccncc5)cc4)c3Cl)c2n1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7009396 0.93 BDKRB2 (0.66) BDKRB2
SCHEMBL7013774 0.90 BDKRB2 (0.64) BDKRB2
SCHEMBL7008473 0.90 BDKRB2 (0.76) BDKRB2
SCHEMBL7011946 0.90 BDKRB2 (0.67) BDKRB2
SCHEMBL7015680 0.90 BDKRB2 (0.79) BDKRB2
SCHEMBL7012003 0.87 BDKRB2 (0.83) BDKRB2
SCHEMBL7012002 0.87 BDKRB2 (0.83) BDKRB2
SCHEMBL7007739 0.86 BDKRB2 (0.59) BDKRB2
SCHEMBL7011669 0.82 BDKRB2 (0.61) BDKRB2
SCHEMBL7010680 0.81 BDKRB2 (0.63) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861243-B1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-11-12 EP disclosed
US-6344462-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-05 US disclosed
US-6100284-A ANTIALLERGENS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-08 US disclosed
US-6008229-A TREATING ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed